Advertisement
Screener

Structure Therapeutics Inc. (GPCR) Other

Structure Therapeutics Inc. Other

Cover page items of the 10-K and 10-Q that have no other home: a security other than the listed stock or a bond, a check box that differs from the latest cover, or a figure not in the Balance Sheet › Equity tabs. Newest first, as filed.

  • 2026-08-06: Form 10-Q; Item Stock registered under Section 12(b); As filed Ordinary shares, par value $0.0001 per share.
  • 2026-05-07: Form 10-Q; Item Stock registered under Section 12(b); As filed Ordinary shares, par value $0.0001 per share.
  • 2026-02-26: Form 10-K; Item Stock registered under Section 12(b); As filed Ordinary shares, par value $0.0001 per share · NASDAQ.
  • 2025-11-06: Form 10-Q; Item Stock registered under Section 12(b); As filed Ordinary shares, par value $0.0001 per share · NASDAQ.
FiledFormItemAs filed
2026-08-0610-QStock registered under Section 12(b)Ordinary shares, par value $0.0001 per share
2026-05-0710-QStock registered under Section 12(b)Ordinary shares, par value $0.0001 per share
2026-02-2610-KStock registered under Section 12(b)Ordinary shares, par value $0.0001 per share · NASDAQ
2025-11-0610-QStock registered under Section 12(b)Ordinary shares, par value $0.0001 per share · NASDAQ
2025-08-0610-QStock registered under Section 12(b)Ordinary shares, par value $0.0001 per share · NASDAQ
2025-05-0810-QStock registered under Section 12(b)Ordinary shares, par value $0.0001 per share · NASDAQ
2025-02-2710-KStock registered under Section 12(b)Ordinary shares, par value $0.0001 per share · NASDAQ
2025-02-2710-KSmaller reporting companyYes
2024-11-1310-QStock registered under Section 12(b)Ordinary shares, par value $0.0001 per share · NASDAQ
2024-11-1310-QSmaller reporting companyYes
2024-11-1310-QEmerging growth companyYes
2024-08-0810-QStock registered under Section 12(b)Ordinary shares, par value $0.0001 per share · NASDAQ
2024-08-0810-QSmaller reporting companyYes
2024-08-0810-QEmerging growth companyYes
2024-05-0910-QStock registered under Section 12(b)Ordinary shares, par value $0.0001 per share · NASDAQ
2024-05-0910-QSmaller reporting companyYes
2024-05-0910-QEmerging growth companyYes
2024-03-0810-KStock registered under Section 12(b)Ordinary shares, par value $0.0001 per share · NASDAQ
2024-03-0810-KSmaller reporting companyYes
2024-03-0810-KEmerging growth companyYes
2024-03-0810-KWell-known seasoned issuerNo
2023-11-1710-QStock registered under Section 12(b)Ordinary shares, par value $0.0001 per share · NASDAQ
2023-11-1710-Q/AStock registered under Section 12(b)Ordinary shares, par value $0.0001 per share · NASDAQ
2023-11-1710-QSmaller reporting companyYes
2023-11-1710-Q/ASmaller reporting companyYes
2023-11-1710-QEmerging growth companyYes
2023-11-1710-Q/AEmerging growth companyYes
2023-11-1610-Q/AStock registered under Section 12(b)Ordinary shares, par value $0.0001 per share · NASDAQ
2023-11-1610-Q/ASmaller reporting companyYes
2023-11-1610-Q/AEmerging growth companyYes
2023-08-1010-QStock registered under Section 12(b)Ordinary shares, par value $0.0001 per share · NASDAQ
2023-08-1010-QSmaller reporting companyYes
2023-08-1010-QEmerging growth companyYes
2023-05-1110-QStock registered under Section 12(b)Ordinary shares, par value $0.0001 per share · NASDAQ
2023-05-1110-QSmaller reporting companyYes
2023-05-1110-QEmerging growth companyYes

Similar stocks

Stock NameCountryMarket CapPE Ratio
Spyre Therapeutics, Inc. (SYRE)United States$7.685B-43.69
Praxis Precision Medicines, Inc. (PRAX)United States$7.884B-27.60
IONIS PHARMACEUTICALS INC (IONS)United States$7.277B-23.25
Alkermes plc. (ALKS)$6.844B132.74
RHYTHM PHARMACEUTICALS, INC. (RYTM)United States$6.771B-37.20
TG THERAPEUTICS, INC. (TGTX)United States$8.805B19.05
Protagonist Therapeutics, Inc (PTGX)United States$8.883B95.52
Liquidia Corp (LQDA)United States$6.347B51.23
Amneal Pharmaceuticals, Inc. (AMRX)$6.326B25.62
CYTOKINETICS INC (CYTK)United States$9.130B-11.86